Aprepitant is a selective neurokinin-1 (NK1) receptor antagonist that blocks substance P-mediated emesis signalling, used in combination antiemetic regimens to prevent chemotherapy-induced nausea and vomiting. Simson Pharma's Aprepitant reference standard and impurities support stability-indicating method development for this supportive-oncology therapy.
Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Aprepitant Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.